Abstract
A genome-wide association study (GWAS) using metabolite concentrations as proxies for enzymatic activity, suggested that two variants: rs2014355 in the gene encoding short-chain acyl-coenzyme A dehydrogenase (ACADS) and rs11161510 in the gene encoding medium-chain acyl-coenzyme A dehydrogenase (ACADM) impair fatty acid β-oxidation. Chronic exposure to fatty acids due to an impaired β-oxidation may down-regulate the glucose-stimulated insulin release and result in an increased risk of type 2 diabetes (T2D). We aimed to investigate whether the two variants associate with altered insulin release following an oral glucose load or with T2D.
Original language | English |
---|---|
Journal | B M C Medical Genetics |
Volume | 12 |
Pages (from-to) | 4 |
ISSN | 1471-2350 |
DOIs | |
Publication status | Published - 2011 |
Keywords
- Adult
- Alleles
- Blood Glucose
- Butyryl-CoA Dehydrogenase
- Case-Control Studies
- Clinical Trials as Topic
- Cohort Studies
- Diabetes Mellitus, Type 2
- Female
- Glucose Tolerance Test
- Humans
- Insulin
- Male
- Middle Aged
- Prevalence